Answers are grounded in this paper and cite their sources.
Demonstrates a gain-of-function factor IX mutation causing juvenile thrombophilia, indicating that hyperactive clotting enzymes drive early thrombosis.
We report a case of juvenile thrombophilia associated with a substitution of leucine for arginine at position 338 (R338L) in the factor IX gene (factor IX-R338L). The level of the mutant factor IX protein in plasma was normal, but the clotting activity of factor IX from the proband was approximately eight times the normal level. In vitro, recombinant factor IX-R338L had a specific activity that was 5 to 10 times as high as that in the recombinant wild-type factor IX. The R338 substitution causes a gain-of-function mutation, resulting in factor IX that is hyperfunctional.
No takes yet. Share an insight, caveat, or question.
Simioni et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: